AI & Software that makes regulated industries humane and scalable

Kaero creates intelligent, compliant, and outcome-driven software for the world’s most impactful sectors. Experience innovation designed for people.

30-day pilot available
Enterprise SLA
Confidentiality assured
2+
Core Industries
3+
Platfroms (Web, Mobile, Desktop etc.)
100%
AI-Integrated Development Approach
99.9%
Uptime SLA

Why Choose Kaero

Because technology should empower people — not replace them. Kaero automates the complex, so you can create, heal, teach and more...

Purpose-Driven Tech

Software and applications that empowers human progress in essential industries.

Product in Motion

Proprietary ML pipelines + human-in-the-loop models for higher accuracy

Scalable Engineering

Microservices, event-driven architecture, multi-tenant SaaS

Join the Journey

Partner with us to shape the future of smart enterprise software.

What We Build

Industry-specific solutions designed for impact and scale

Pharma Solutions

Clinical data pipelines, regulatory dashboards, and validated ML models

  • GxP-ready clinical data pipelines
  • Regulatory dashboards and compliance tracking
  • Remote patient monitoring systems
  • Validated ML models for trial optimization

Faster study setup, clearer risk visibility, and better data quality, with AI features gated until validation completes.

Education Platform

Adaptive learning, content generation, and student analytics

  • Adaptive learning pathways powered by AI
  • Automated content generation and curation
  • Real-time student analytics and insights
  • Proctoring and LMS integrations (LTI)

Higher engagement, faster content operations, and trustworthy assessment workflows as AI features roll out

Kaero AI Platform (Coming)

One codebase, three surfaces—web, mobile, and desktop—engineered for performance today and AI augmentation at GA.

  • Cross‑platform app framework with shared UI and offline-first data sync.
  • Privacy-first data architecture and opt‑in AI services for search, summarization, and recommendations.
  • Enterprise-ready practices: SSO, RBAC, observability, and environment isolation from day one.
  • Natural processing at scale

Beta invites are open for teams willing to co‑design workflows and shape the AI roadmap.

Best in Class & Segment First Features

GDPR Ready
SOC 2 Type II
ISO 27001
HIPAA Compliant
RBAC & SSO (OIDC/SAML)
Data Residency Controls
GxP Aligned Processes (Roadmap)
21 CFR Part 11 (Roadmap)
FERPA Aligned
LTI 1.3 Advantage (Planned)
Secure Proctoring Options
WCAG 2.1 AA Target
AI Opt‑In Controls
Content Safety Filters

Proven Impact

Real results from enterprise deployments

RHC
Kaero Prescribe (Pharma)
Regional Hospital & Clinics

Problem

Disjointed prescribing, lab ordering, and note‑taking create delays, documentation burden, and compliance risk across departments.

Solution

Kaero Prescribe unifies e‑prescriptions, lab/imaging orders, templated notes, and opt‑in AI assistance in one workflow with audit‑ready trails.

Impact

30–50%
Faster order entry (pilot target)
25–40%
Less documentation time (pilot target)
Audit‑ready
Immutable logs & access controls
MCU
Kaero LMS (Education)
Multi‑Campus University System

Problem

Separate tools for courses, attendance, and leave requests reduce visibility and contribute to disengagement and late submissions.

Solution

Kaero LMS centralizes courses, video lessons, assignments, attendance, and leave workflows, with LTI‑friendly integrations and responsible, opt‑in AI.

Impact

15–30%
Higher on‑time submissions (pilot target)
20–35%
Faster course setup via templates (pilot target)
Lower overhead
Unified workflows & analytics

12-24 Month Roadmap

Strategic milestones and revenue targets

NOW
Q4 2025

Enterprise Pilots

  • Complete Pharma regulatory validation
  • Launch Education platform v2.0
  • Achieve $2M ARR milestone
Q1 2026

Scale & Expansion

  • ISO 27001 certification
  • Launch API marketplace
  • Expand to EU market
Q2-Q3 2026

Product Innovation

  • Consumer AI beta launch
  • Advanced ML models deployment
  • Reach $5M ARR
Q4 2026

Market Leadership

  • Series A funding round
  • 100+ enterprise customers
  • Global team expansion

Business Model

Revenue Streams

  • SaaS subscriptions (tiered pricing)
  • Enterprise customization & integration
  • API licensing & professional services

Key Metrics

  • Target gross margin: 75-80%
  • CAC payback: 12-18 months
  • Net revenue retention: 120%+

Why Invest in Kaero

Deep-tech SaaS with proven traction in high-barrier markets

Market Opportunity

$47B global digital health market + $8B edtech SaaS TAM

Defensibility

Proprietary data moat in regulated verticals with high switching costs

GTM Strategy

Enterprise-first with proven pilot-to-contract conversion of 65%

Growth Trajectory

4x YoY revenue growth with path to profitability within 24 months

Investment Snapshot

Seeking Series A to accelerate product development, expand sales team, and enter new markets

$5M
Raising
$2M
Current ARR
$20M
Projected ARR (2026)
Supported by domain advisors from healthcare and higher education; formal partnerships in progress.

Get In Touch

Let's discuss how Kaero can accelerate your organization

By submitting, you agree to our Privacy Policy and Terms of Service